1 |
Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249.
|
2 |
Huang SH, O’sullivan B. Overview of the 8th edition TNM classification for head and neck cancer[J]. Curr Treat Options Oncol, 2017, 18(7): 40.
|
3 |
Peng QS, Cheng YN, Zhang WB, et al. circRNA_0000-140 suppresses oral squamous cell carcinoma growth and metastasis by targeting miR-31 to inhibit Hippo signaling pathway[J]. Cell Death Dis, 2020, 11(2): 112.
|
4 |
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132.
|
5 |
Warnakulasuriya S. Global epidemiology of oral and o-ropharyngeal cancer[J]. Oral Oncol, 2009, 45(4/5): 309-316.
|
6 |
Xia C, Dong X, Li H, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants[J]. Chin Med J (Engl), 2022, 135(5): 584-590.
|
7 |
Mohan SP, Bhaskaran MK, George AL, et al. Immunotherapy in oral cancer[J]. J Pharm Bioallied Sci, 2019, 11(): S107-S111.
|
8 |
Fan T, Wang X, Zhang S, et al. NUPR1 promotes the proliferation and metastasis of oral squamous cell carcinoma cells by activating TFE3-dependent autophagy[J]. Signal Transduct Target Ther, 2022, 7(1): 130.
|
9 |
SHahinas J, Hysi D. Methods and risk of bias in molecular marker prognosis studies in oral squamous cell carcinoma[J]. Oral Dis, 2018, 24(1/2): 115-119.
|
10 |
Teveroni E, Di Nicuolo F, Bianchetti G, et al. Nuclear localization of PTTG1 promotes migration and invasion of Seminoma tumor through activation of MMP-2[J]. Cancers (Basel), 2021, 13(2): 212.
|
11 |
Salehi F, Kovacs K, Scheithauer BW, et al. Pituitary tumor-transforming gene in endocrine and other neopla-sms: a review and update[J]. Endocr Relat Cancer, 2008, 15(3): 721-743.
|
12 |
Horning AM, Wang Y, Lin CK, et al. Single-cell RNA-seq reveals a subpopulation of prostate cancer cells with enhanced cell-cycle-related transcription and attenuated androgen response[J]. Cancer Res, 2018, 78(4): 853-864.
|
13 |
Long L, Gao J, Zhang R. PTTG1 enhances oncolytic a-denovirus 5 entry into pancreatic adenocarcinoma cells by increasing CXADR expression[J]. Viruses, 2023, 15(5): 1153.
|
14 |
Huang S, Liao Q, Li W, et al. The lncRNA PTTG3P promotes the progression of CRPC via upregulating PTTG1[J]. Bull Cancer, 2021, 108(4): 359-368.
|
15 |
Deng P, Tan M, Zhou W, et al. Bisphenol A promotes breast cancer cell proliferation by driving miR-381-3p-PTTG1-dependent cell cycle progression[J]. Chemos-phere, 2021, 268: 129221.
|
16 |
Guo XC, Li L, Gao ZH, et al. The long non-coding RNA PTTG3P promotes growth and metastasis of cervical can-cer through PTTG1[J]. Aging, 2019, 11(5): 1333-1341.
|
17 |
Goldman MJ, Craft B, Hastie M, et al. Visualizing and interpreting cancer genomics data via the Xena platform[J]. Nat Biotechnol, 2020, 38(6): 675-678.
|
18 |
Li JH, Liu S, Zhou H, et al. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data[J]. Nucleic Acids Res, 2014, 42(Database issue): D92-D97.
|
19 |
Chandrashekar DS, Karthikeyan SK, Korla PK, et al. UALCAN: an update to the integrated cancer data analysis platform[J]. Neoplasia, 2022, 25: 18-27.
|
20 |
Vejnar CE, Zdobnov EM. MiRmap: comprehensive prediction of microRNA target repression strength[J]. Nucleic Acids Res, 2012, 40(22): 11673-11683.
|
21 |
Zhang G, Li H, Sun R, et al. Long non-coding RNA ZE-B2-AS1 promotes the proliferation, metastasis and epithelial mesenchymal transition in triple-negative breast cancer by epigenetically activating ZEB2[J]. J Cell Mol Med, 2019, 23(5): 3271-3279.
|
22 |
Sasahira T, Kirita T. Hallmarks of cancer-related newly prognostic factors of oral squamous cell carcinoma[J]. Int J Mol Sci, 2018, 19(8): 2413.
|
23 |
Tian X, Xu WH, Xu FJ, et al. Identification of prognostic biomarkers in papillary renal cell carcinoma and PTT-G1 may serve as a biomarker for predicting immunotherapy response[J]. Ann Med, 2022, 54(1): 211-226.
|
24 |
张国新, 徐新伟, 孟斌, 等. miR-186-5p通过靶向调控PTTG1抑制肺腺癌细胞的上皮-间质转化[J]. 中国生物化学与分子生物学报, 2017, 33(4): 380-385.
|
|
Zhang GX, Xu XW, Meng B, et al. miR-186-5p inhibits epithelial mesenchymal transition in lung adenocarcinoma cells through modulating PTTG1[J]. Chin J Biochem Mol Biol, 2017, 33(4): 380-385.
|
25 |
Malik MT, Kakar SS. Regulation of angiogenesis and invasion by human Pituitary tumor transforming gene (PT-TG) through increased expression and secretion of matrix metalloproteinase-2 (MMP-2)[J]. Mol Cancer, 2006, 5: 61.
|
26 |
Gebert LFR, Macrae IJ. Regulation of microRNA function in animals[J]. Nat Rev Mol Cell Biol, 2019, 20(1): 21-37.
|
27 |
Lu TX, Rothenberg ME. MicroRNA[J]. J Allergy Clin Immunol, 2018, 141(4): 1202-1207.
|
28 |
Treiber T, Treiber N, Meister G. Regulation of microRNA biogenesis and its crosstalk with other cellular pathways[J]. Nat Rev Mol Cell Biol, 2019, 20(1): 5-20.
|
29 |
Li C, Yang Y, Wang H, et al. miR-362-3p suppresses o-varian cancer by inhibiting LRP8[J]. Transl Oncol, 2022, 15(1): 101284.
|
30 |
Meng Z, Zhu S, Liu N, et al. miR-362-3p suppresses sinonasal squamous cell carcinoma progression via directly targeting pituitary tumor-transforming gene 1[J]. J Recept Signal Transduct Res, 2022, 42(1): 43-51.
|